Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 28.8K citations · Full text

Clinical Course, Epidemiological Trend, Retrospective Cohort Study +11

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.6K citations · Full text

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Bin Cao, Yeming Wang, Danning Wen et al. · New England Journal of Medicine · 2020 · 5.5K citations · Full text

Marginal Structural Models and Causal Inference in Epidemiology

James M. Robins, Miguel A. Hernán, Babette Brumback · Epidemiology · 2000 · 5.4K citations

Causal Model, Epidemiology, Health Economics +15

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 4.9K citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Antiviral Drug +4